Familial hypercholesterolemia is one of the most clinically relevant monogenic disorders contributing to the development of atherosclerotic cardiovascular disease.
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
A strong association between statin use and incidence of eczema, especially in older patient populations, suggests that assessment for predisposing factors are in order.
Nexlizet (bempedoic acid and ezetimibe; Esperion) is now available for use as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.
Fasting plasma of apolipoprotein B48 concentrations in adolescents were found to beassociated with measures of adiposity and features of the metabolic syndrome in adolescents.
Greater capacities in 3 key measures of high-density lipoprotein functionality were found to be associated with a reduced risk for cardiovascular disease.
